Showing 1 - 6 results of 6 for search 'Marjolein W.M. van derPoel', query time: 0.03s
Refine Results
-
1
The impact of prior malignancies on the development of second malignancies and survival in follicular lymphoma: A population‐based study by Manette A.W. Dinnessen, Otto Visser, Sanne H. Tonino, Marjolein W.M. van derPoel, Nicole M.A. Blijlevens, Marie José Kersten, Pieternella J. Lugtenburg, Avinash G. Dinmohamed
Published 2020-11-01
Article -
2
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities by Janneke W. de Boer, Kylie Keijzer, Elise R. A. Pennings, Jaap A. van Doesum, Anne M. Spanjaart, Margot Jak, Pim G. N. J. Mutsaers, Suzanne van Dorp, Joost S. P. Vermaat, Marjolein W. M. van der Poel, Lisanne V. van Dijk, Marie José Kersten, Anne G. H. Niezink, Tom van Meerten
Published 2023-11-01
Article -
3
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma by Diana Al-Sarayfi, Frederik O. Meeuwes, Müjde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Böhmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland
Published 2022-09-01
Article -
4
P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY by Elise R.A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F.M. Posthuma, Djamila E. Issa, Martine E.D. Chamuleau, Anne M. Spanjaart, Tom van Meerten, Pim G.N.J. Mutsaers, Margot Jak, Suzanne van Dorp, Joost S.P. Vermaat, Marjolein W.M. van der Poel, Maria T. Kuipers, Frederick W. Thielen, Carin A. Uyl-de Groot, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Published 2023-08-01
Article -
5
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy... by Anne M. Spanjaart, Elise R. A. Pennings, Pim G. N. J. Mutsaers, Suzanne van Dorp, Margot Jak, Jaap A. van Doesum, Janneke W. de Boer, Anne G. H. Niezink, Milan Kos, Joost S. P. Vermaat, Aniko Sijs-Szabo, Marjolein W. M. van der Poel, Inger S. Nijhof, Maria T. Kuipers, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Jeanette K. Doorduijn, Yasmina I. M. Serroukh, Monique C. Minnema, Tom van Meerten, Marie José Kersten
Published 2023-08-01
Article -
6
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine by Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls
Published 2023-06-01
Article